# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-25-111287
Filing Date
2025-11-13
Accepted
2025-11-13 16:09:43
Documents
32
Period of Report
2025-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2531076d1_8k.htm iXBRL | 8-K | 26561
2 | EXHIBIT 99.1 | tm2531076d1_ex99-1.htm | EX-99.1 | 586160
3 | EXHIBIT 99.2 | tm2531076d1_ex99-2.htm | EX-99.2 | 28554
7 | GRAPHIC | tm2531076d1_ex99-1img001.jpg | GRAPHIC | 2232
8 | GRAPHIC | tm2531076d1_ex99-2img001.jpg | GRAPHIC | 177452
9 | GRAPHIC | tm2531076d1_ex99-2img002.jpg | GRAPHIC | 491308
10 | GRAPHIC | tm2531076d1_ex99-2img003.jpg | GRAPHIC | 486593
11 | GRAPHIC | tm2531076d1_ex99-2img004.jpg | GRAPHIC | 257161
12 | GRAPHIC | tm2531076d1_ex99-2img005.jpg | GRAPHIC | 338696
13 | GRAPHIC | tm2531076d1_ex99-2img006.jpg | GRAPHIC | 390321
14 | GRAPHIC | tm2531076d1_ex99-2img007.jpg | GRAPHIC | 328505
15 | GRAPHIC | tm2531076d1_ex99-2img008.jpg | GRAPHIC | 339844
16 | GRAPHIC | tm2531076d1_ex99-2img009.jpg | GRAPHIC | 298363
17 | GRAPHIC | tm2531076d1_ex99-2img010.jpg | GRAPHIC | 399021
18 | GRAPHIC | tm2531076d1_ex99-2img011.jpg | GRAPHIC | 152152
19 | GRAPHIC | tm2531076d1_ex99-2img012.jpg | GRAPHIC | 578131
20 | GRAPHIC | tm2531076d1_ex99-2img013.jpg | GRAPHIC | 268217
21 | GRAPHIC | tm2531076d1_ex99-2img014.jpg | GRAPHIC | 413686
22 | GRAPHIC | tm2531076d1_ex99-2img015.jpg | GRAPHIC | 263834
23 | GRAPHIC | tm2531076d1_ex99-2img016.jpg | GRAPHIC | 352551
24 | GRAPHIC | tm2531076d1_ex99-2img017.jpg | GRAPHIC | 207999
| Complete submission text file | 0001104659-25-111287.txt |  | 8749085

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | hypd-20251113.xsd | EX-101.SCH | 3026
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | hypd-20251113_lab.xml | EX-101.LAB | 34239
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | hypd-20251113_pre.xml | EX-101.PRE | 22366
34 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2531076d1_8k_htm.xml | XML | 3690

Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 251478510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)